Skip to main content
S&P 5007,805.45-0.08%DOW51,670.10+0.03%NASDAQ27,204.38-0.15%BTC$83,383.00+2.60%ETH$2,506.39+3.61%GOLD$4,179.30+0.05%OIL$94.91+0.82%
Smart Investors Daily
SID Premium
AN

NYSE · ANSLY

Ansell Limited

Healthcare · Medical - Instruments & Supplies

$124.00

Up+$0.00 (+0.00%)

Updated Oct 14, 2026, 9:26 AM

SID Score

5.3/10

Composite research score

Smart Money

50/100

Neutral

Market cap
3.31B
P/E ratio
23.95
Dividend yield
1.61%
52-week range
— – —
Volume
3
Avg. volume
3

Price performance · ANSLY

ANSLY price history

1M range · 0 trading sessions · Daily adjusted prices

ANSLY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest ANSLY news

The latest Smart Investors Daily articles mentioning ANSLY.

Stock researchCompany · Overview

ANSLY research

Overview

Company profile and research snapshot.

Company profile

ANSELL LTD S/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$95.49
Implied upside
—
Analysts
12
ANSLY recent ratings
DateFirmRatingTarget
Sep 2, 2026JEFFERIESBuy—
Aug 25, 2026MACQUARIE RESEARCHNeutral—
Jun 19, 2026MACQUARIE RESEARCHNeutral—
Jun 18, 2026MACQUARIE RESEARCHNeutral—
Mar 2, 2026JEFFERIESBuy—
Open full forecast

News briefing

Generated Oct 13, 2026, 9:02 PM

What's Happening With ANSLY? Valuation Opportunity Emerges for Ansell Limited

Ansell Limited has caught the attention of value-focused investors as it appears in recent screening lists for significantly undervalued stocks. The company is being highlighted as trading substantially below fair value estimates, suggesting potential upside for contrarian investors willing to take a position at current depressed levels.

    Bottom line: Ansell Limited presents a classic value opportunity for investors comfortable with higher risk, trading at what appears to be a substantial discount to fair value estimates. However, the depth of the valuation discount warrants careful due diligence to confirm the market's pessimism isn't justified by deteriorating fundamentals or structural headwinds facing the business.

    Yahoo · Oct 12, 2026

    3 Australian Stocks Trading Up To 43% Below Fair Value

    Artificial intelligence is drawing huge investment worldwide, and Intel and Broadcom now flag that access to capital is becoming a real bottleneck for this boom. When money gets more selective, companies that already produce solid cash and trade below what detailed cash flow models suggest can look especially interesting. This article highlights three Australian stocks that fit that profile and shows how their cash generation supports today’s discounted prices. The three stocks below are just...

    Yahoo · Oct 12, 2026

    Elite Undervalued Stocks To Own In October 2026

    Bond yields worldwide are surging, and higher discount rates are putting extra pressure on richly priced stocks. That is painful for investors anchored to momentum stories. It can be helpful if you are hunting for businesses where the cash coming in looks solid but the share price has not kept up. This article highlights three companies that screen as potentially mispriced on cash flows right now. The companies covered below are just a small sample, and the same cash flow lens currently...

    AI research layers

    Interpretive context generated from the platform’s current data sources.

    No results

    AI research layers have not been published yet.

    Featured By